Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Jung Yang

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Retrovirology|August 8, 2015
Determinants in HIV-2 Env and tetherin required for functional interactionColin M Exline, Su Jung Yang, Kevin G Haworth, et al.
Plos One|March 9, 2013
Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1Su-Jung Yang, Chen-Yu Chen, Geen-Dong Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2023
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cellsPeter J Cook, Su Jung Yang, Gene I Uenishi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 15, 2026
Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disordersYuchi Honaker, Noelle P Dahl, Swati Singh, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Retrovirology|August 8, 2015
Determinants in HIV-2 Env and tetherin required for functional interactionColin M Exline, Su Jung Yang, Kevin G Haworth, et al.
Plos One|March 9, 2013
Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1Su-Jung Yang, Chen-Yu Chen, Geen-Dong Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2023
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cellsPeter J Cook, Su Jung Yang, Gene I Uenishi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 15, 2026
Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disordersYuchi Honaker, Noelle P Dahl, Swati Singh, et al.
Pageof 2